Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-003665

Options or other derivatives

  • General Counsel acquired 15,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MOORE JOHN R · General Counsel

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-01 Grant or award : show line 1 in the form Restricted Stock Units +15,625 15,625 D
Loading xslF345X03/primarydocument.xml…